ORGO

Organogenesis Holdings Inc. (ORGO) is a prominent leader in regenerative medicine, focused on pioneering allograft products and bioactive therapies tailored for advanced wound care, surgical, and sports medicine applications across the United States. Based in Canton, Massachusetts, the company emphasizes innovation and product quality, catering to a growing demand for effective regenerative healthcare solutions. With a strong commitment to enhancing patient outcomes, Organogenesis is strategically positioned to capitalize on emerging growth opportunities within the dynamic healthcare sector, making it an attractive investment for institutional stakeholders.